Traditional and Novel Risk Factors in Atherothrombosis / / edited by Efrain Gaxiola.
Atherothrombosis has reached pandemic proportions worldwide. It is the underlying condition that results in events leading to myocardial infarction, ischemic stroke and vascular death. As such, it is the leading cause of death worldwide manifested mainly as cardiovascular/cerebrovascular death. The...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Croatia : : IntechOpen,, 2012. |
Year of Publication: | 2012 |
Language: | English |
Physical Description: | 1 online resource (154 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993547422204498 |
---|---|
ctrlnum |
(CKB)3230000000077140 (NjHacI)993230000000077140 (oapen)https://directory.doabooks.org/handle/20.500.12854/66008 (EXLCZ)993230000000077140 |
collection |
bib_alma |
record_format |
marc |
spelling |
Gaxiola, Efrain edt Traditional and Novel Risk Factors in Atherothrombosis / edited by Efrain Gaxiola. IntechOpen 2012 Croatia : IntechOpen, 2012. 1 online resource (154 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Atherothrombosis has reached pandemic proportions worldwide. It is the underlying condition that results in events leading to myocardial infarction, ischemic stroke and vascular death. As such, it is the leading cause of death worldwide manifested mainly as cardiovascular/cerebrovascular death. The complex and intimate relationship between atherothrombosis and traditional and novel risk factors is discussed in the following chapters of Traditional and Novel Risk Factors in Atherothrombosis - from basic science to clinical and therapeutic concerns. Beginning with pathology and pathophysiology of atherothrombosis, plaque rupture/disruption, this book continues with molecular, biochemical, inflammatory, cellular aspects and finally analyzes several aspects of clinical pharmacology. English Cardiovascular pharmacology. Cardiovascular medicine 953-51-0561-2 Gaxiola, Efrain, editor. |
language |
English |
format |
eBook |
author2 |
Gaxiola, Efrain, |
author_facet |
Gaxiola, Efrain, |
author2_variant |
e g eg e g eg |
author2_role |
TeilnehmendeR |
title |
Traditional and Novel Risk Factors in Atherothrombosis / |
spellingShingle |
Traditional and Novel Risk Factors in Atherothrombosis / |
title_full |
Traditional and Novel Risk Factors in Atherothrombosis / edited by Efrain Gaxiola. |
title_fullStr |
Traditional and Novel Risk Factors in Atherothrombosis / edited by Efrain Gaxiola. |
title_full_unstemmed |
Traditional and Novel Risk Factors in Atherothrombosis / edited by Efrain Gaxiola. |
title_auth |
Traditional and Novel Risk Factors in Atherothrombosis / |
title_new |
Traditional and Novel Risk Factors in Atherothrombosis / |
title_sort |
traditional and novel risk factors in atherothrombosis / |
publisher |
IntechOpen IntechOpen, |
publishDate |
2012 |
physical |
1 online resource (154 pages) |
isbn |
953-51-6982-3 953-51-0561-2 |
callnumber-first |
R - Medicine |
callnumber-subject |
RM - Therapeutics and Pharmacology |
callnumber-label |
RM345 |
callnumber-sort |
RM 3345 T733 42012 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
615 - Pharmacology & therapeutics |
dewey-full |
615.71 |
dewey-sort |
3615.71 |
dewey-raw |
615.71 |
dewey-search |
615.71 |
work_keys_str_mv |
AT gaxiolaefrain traditionalandnovelriskfactorsinatherothrombosis |
status_str |
n |
ids_txt_mv |
(CKB)3230000000077140 (NjHacI)993230000000077140 (oapen)https://directory.doabooks.org/handle/20.500.12854/66008 (EXLCZ)993230000000077140 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Traditional and Novel Risk Factors in Atherothrombosis / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796652246417539072 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00903nam a2200277 i 4500</leader><controlfield tag="001">993547422204498</controlfield><controlfield tag="005">20221010202557.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221010s2012 ci o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-6982-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3230000000077140</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)993230000000077140</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/66008</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993230000000077140</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM345</subfield><subfield code="b">.T733 2012</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">615.71</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gaxiola, Efrain</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Traditional and Novel Risk Factors in Atherothrombosis /</subfield><subfield code="c">edited by Efrain Gaxiola.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2012</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Croatia :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (154 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Atherothrombosis has reached pandemic proportions worldwide. It is the underlying condition that results in events leading to myocardial infarction, ischemic stroke and vascular death. As such, it is the leading cause of death worldwide manifested mainly as cardiovascular/cerebrovascular death. The complex and intimate relationship between atherothrombosis and traditional and novel risk factors is discussed in the following chapters of Traditional and Novel Risk Factors in Atherothrombosis - from basic science to clinical and therapeutic concerns. Beginning with pathology and pathophysiology of atherothrombosis, plaque rupture/disruption, this book continues with molecular, biochemical, inflammatory, cellular aspects and finally analyzes several aspects of clinical pharmacology.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cardiovascular pharmacology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cardiovascular medicine</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-0561-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gaxiola, Efrain,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 19:49:23 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2012-12-09 08:17:33 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338569180004498&Force_direct=true</subfield><subfield code="Z">5338569180004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338569180004498</subfield></datafield></record></collection> |